Illumina to acquire Peninsula cancer detection biotech Grail in $8 billion deal
The agreement comes after Menlo Park-based Grail filed plans earlier in September to go public later in the year.
Full Article
Illumina to acquire Peninsula cancer detection biotech Grail in $8 billion deal
bizjournals
0 shares
1 views
You might like
Related news coverage
Illumina To Acquire GRAIL In $8 Bln Cash, Stock Deal
Biotech company Illumina agreed to buy healthcare company GRAIL, Inc. in a cash and stock deal valued at $8 billion. This includes..
RTTNews